MA
MRNA icon

MUFG Americas’s Moderna MRNA Stock Holding History

MUFG Americas’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-500
Closed -$86K – 788
2022
Q1 		$86K Hold
500
– – ﹤0.01% 466
2021
Q4 		$127K Hold
500
– – ﹤0.01% 435
2021
Q3 		$192K Hold
500
– – ﹤0.01% 392
2021
Q2 		$117K Hold
500
– – ﹤0.01% 417
2021
Q1 		$65K Hold
500
– – ﹤0.01% 484
2020
Q4 		$52K Hold
500
– – ﹤0.01% 501
2020
Q3 		$35K Buy
+500
New +$34.9K ﹤0.01% 509

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MUFG Americas's MRNA Position: Q2 2022 in Review

MUFG Americas sold out of Moderna (MRNA) in Q2 2022, closing a stake of 500 shares — an estimated $86K sold.

MUFG Americas first reported a position in MRNA in Q3 2020 and held it in 7 quarters. The position peaked at $192K in Q3 2021. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • MUFG Americas reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
  • MUFG Americas sold 500 Moderna shares in Q2 2022, an estimated $86K.
  • MUFG Americas first reported a position in Moderna in Q3 2020 and held it in 7 quarters.
  • MUFG Americas's Moderna position peaked at $192K in Q3 2021.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on MUFG Americas's 13F filing for Q2 2022, filed 2 Aug 2022.